JUNSHI BIO (01877) has announced that its controlling shareholder, one of the actual controllers, and Chairman, Mr. Xiong Jun, plans to increase his holdings of the company's A-shares and H-shares over a 12-month period starting April 12, 2025. The planned acquisitions will be made through permissible methods on the Shanghai Stock Exchange and The Stock Exchange of Hong Kong Limited, including but not limited to centralized bidding and block trades, with a total intended investment of no less than RMB 100 million. The portion allocated to A-share purchases is specified to be no less than RMB 50 million.

As of the date of this announcement, Mr. Xiong has already acquired a cumulative total of 100,000 A-shares via the Shanghai Stock Exchange's centralized bidding system. These shares represent approximately 0.01% of the company's total share capital, with a cumulative transaction value of RMB 3.8384 million.

The share acquisition plan is still in progress and has not yet been completed. Mr. Xiong will continue to implement the plan and make further purchases at opportune times during the specified implementation period.